Alkermes
evolution of alkermes strategy legacy strategy target evaluation driven by potential to add new medical value to established medications enabled rapid advancement to late stage development yielded advanced formulation science chemistry and drug delivery technologies applied to improve established pharmacology under review june | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
5 of 144
Related slides by other companies
Sarissa Capital
Activist
June 2023
alkermes argument to exclude candidacy because of his biogen directorship is now moot biogen announces changes to its board of directors | Sarissa Capital
Allwyn
Investor Conference
March 2023
embraces | Allwyn
Salvatore Ferragamo
Investor Day
May 2022
elements of our strategy | Salvatore Ferragamo
Berkeley Lights
Investor Conference
January 2022
established pillars of our growth strategy | Berkeley Lights
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io